Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

EONS16: Opening session & Keynote lectures

CN1 - Integrating an electronic patient reported outcome measure (ePROM) into a nurse-led rare cancer pathway

Date

21 Oct 2023

Session

EONS16: Opening session & Keynote lectures

Presenters

Jane Ireson

Citation

Annals of Oncology (2023) 34 (suppl_2): S1229-S1256. 10.1016/annonc/annonc1321

Authors

J. Ireson1, T. Holch2, D. Greenfield3, K. Singh1, S. Gillett1, S. Rollins1, S. Radley4, J. Tidy1, G. Jones2

Author affiliations

  • 1 Sheffield Trophoblastic Screening And Treatment Centre, Weston Park Hospital - Sheffield Teaching Hospitals NHS Foundation Trust, S10 2SJ - Sheffield/GB
  • 2 Centre For Psychological Research, Leeds Beckett University, Leeds/GB
  • 3 Weston Park Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, S10 2SJ - Sheffield/GB
  • 4 Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, S5 7AU - Sheffield/GB

Resources

This content is available to ESMO members and event participants.

Abstract CN1

Background

The use of ePROMs in clinical practice has the potential to generate population level patient-reported outcome data alongside promoting patient-centred care and improving patients’ quality of life. Individualised PROMs may be particularly helpful in identifying, prioritising, and discussing health concerns, yet little research in cancer nursing has evaluated this. Gestational Trophoblastic Disease (GTD) is a rare complication of pregnancy that can present as or turn into cancer. This nurse-led research group has recently developed a GTD specific ePROM (ePAQ-GTD) that has been integrated into the GTD pathway to support population level research and deliver tailored virtual nurse-led patient centred care.

Methods

From January 2020, ePAQ-GTD and a new nurse-led virtual clinic were offered to all GTD patients at a regional GTD centre at referral, start of treatment, end of treatment, 6 weeks, 6 months, and yearly post chemotherapy. Feedback of ePAQ-GTD responses were provided ahead of the clinic in the form of an electronic summary report. Reflexive thematic analysis of qualitative interviews with a purposive sample of GTD patients (n=15) and GTD nurses (n=3) was conducted for an in-depth evaluation of ePAQ-GTD’s use as an outcome measure used routinely in clinical practice.

Results

The results of the analysis identified three key themes, firstly that patients and staff found ePAQ-GTD demonstrated content validity and was a relevant and acceptable tool to capture the impact of GTD and its treatment from the patient perspective. Secondly, ePAQ-GTD facilitated and enabled important discussions to happen in the virtual nurse-led clinic, especially around taboo subjects such as sexual dysfunction and mental health emphasising its comprehensiveness and patient-centredness. Lastly, the feedback of ePAQ-GTD results in the context of a nurse-led clinic was linked to improvements in wellbeing through improved communication, empowerment and decision making.

Conclusions

Findings suggest ePAQ-GTD has content validity as an outcome measure. The feedback of ePAQ-GTD results in a virtual nurse-led clinic also shows benefits in relation to communication, empowerment and decision making when integrated into a nurse-led cancer pathway for GTD.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

Sheffield Teaching Hospital NHS Foundation Trust.

Funding

National Institute of Health Research (NIHR).

Disclosure

S. Radley: Non-Financial Interests, Leadership Role: ePAQ. All other authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.